Evidence map›Paper›PMID 42095474›Full record

ArticleEuropean journal of immunology2026

CD8 T Cell Sensing of Type I Interferon Impacts Anergy.

Anne S Haefke, Hanna Gröber, Ioana Sandu, Vanessa Skipness, Nikos Pantouloufos, Fabienne Gräbnitz, Marie-Elen Tuchel, Nathan Zangger, Dominique Stark, Marvin Kříž and 5 more

Abstract read
In one paragraph

Article in European journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anne S HaefkeInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Hanna GröberInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Ioana SanduInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Vanessa SkipnessInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Nikos PantouloufosInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Fabienne GräbnitzInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Marie-Elen TuchelInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Nathan ZanggerInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Dominique StarkInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Marvin KřížInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Carmine CristinzioInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Hanspeter PircherMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Roman SpörriInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Isaak QuastInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Annette OxeniusInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.

Funding

ETH Zurich (Eidgenössische Technische Hochschule Zürich)Max-Planck-GesellschaftPromedica StiftungSwiss National Science Foundation (Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung) 208024
6 · The paper itself

Abstract

Peripheral tolerance is indispensable for the maintenance of immune homeostasis, allowing protective immunity while limiting responses to self-antigens. CD8 T cells activated in the absence of co-stimulation and pro-inflammatory cytokines are either deleted, rendered anergic, or actively suppressed. These mechanisms are well established, but the cues determining the mode and depth of peripheral tolerance remain incompletely understood. Here, we identify type I interferon (IFN-I) signalling in T cells as a key modulator of peripheral tolerance in the absence of infection. In the complete absence of IFN-I signalling, autoreactive CD8 T cells are rendered anergic, and their expansion, phenotype and function are tightly controlled. Basal levels of IFN-I are sufficient for self-reactive CD8 T cells to expand and retain partial effector functions in the absence of viral infections. This is dependent on T cell-intrinsic IFN-I sensing and is associated with the generation of a partially anergic, TCF1

Indexed as

CD8-Positive T-LymphocytesClonal AnergyInterferon Type IAnimalsAutoimmunityImmune ToleranceLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutPeripheral ToleranceSignal TransductionInterferon Type IanergyautoimmunityCD8 T cellsperipheral tolerancetype I interferon

Identifiers

PMID42095474
PMCPMC13150955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.